22:27 IST
NSE
Management Change
Mankind Pharma Management Change
Mankind Pharma announced the cessation of Mr. Bharat Anand as an Independent Director, effective August 30, 2026, upon the completion of his second term.
Mankind Pharma Ltd
- Share price
- ₹2,500.00
- Market cap
- ₹1,03,261 Cr
- Revenue (annual)
- ₹14,278 Cr
- Net profit (annual)
- ₹1,913 Cr
- P/E (TTM)
- 50.5×Sector 47.3×
- Promoter holding
- 72.63%-0.03% QoQ
- FII holding
- 9.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 4Other Announcement 2Management Change 2Employee Stock Options 2Annual General Meeting 2Share Pledge 1Partnership 1
Time
2 announcements with these filters
16:10 IST
BSE
Management Change
Mankind Pharma Management Change
Mankind Pharma has appointed Mr. Anish Vanraj Bafna as an Additional Director (Non-Executive Independent Director), effective August 10, 2026.